Third Roundtable Examines Personalized Medicine and the #Path2Cures
WASHINGTON, DC – The Energy and Commerce Committee today held its third roundtable discussion in the 21st Century Cures initiative. Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO) led the discussion on personalized medicine with participants from the U.S. Food and Drug Administration, the Ovarian Cancer Society, Leukemia and Lymphoma Society, MD Anderson, Duke University Health System, Genentech, Mayo Clinic, American College of Cardiology, Abbott Molecular, the Personalized Medicine Coalition, and Apple Tree Partners. Participants discussed how advances in areas such as genomic sequencing and diagnostic testing can accelerate the pace of cures.
“21st Century Cures touches all Americans as they, their families, or their friends have been affected by disease. Through our work on this initiative, we have found that much hard work remains to finding and delivering cures and treatments for the approximately 95 percent of diseases without them. But we’ve also seen an outpouring of support and enthusiasm to work together and achieve this common goal,” commented Chairman Upton. “We also know that every patient is different and that we need to foster innovation to better understand those differences and find the best treatments for each patient.”
“We know that many advancements in science and technology have been made that can lead to more successful developments and treatments in cures.” DeGette added, “As we learn more about the science, we can target potential treatments and cures more effectively on impacted populations.”